Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models.

Limon JJ, Tang J, Li D, Wolf AJ, Michelsen KS, Funari V, Gargus M, Nguyen C, Sharma P, Maymi VI, Iliev ID, Skalski JH, Brown J, Landers C, Borneman J, Braun J, Targan SR, McGovern DPB, Underhill DM.

Cell Host Microbe. 2019 Mar 13;25(3):377-388.e6. doi: 10.1016/j.chom.2019.01.007. Epub 2019 Mar 5.

PMID:
30850233
2.

Mucosal immune responses to fungi and the implications for inflammatory bowel disease.

Limon JJ, Kershaw KM, Underhill DM.

Curr Opin Gastroenterol. 2018 Nov;34(6):398-403. doi: 10.1097/MOG.0000000000000483.

PMID:
30299290
3.

Expansion of commensal fungus Wallemia mellicola in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice.

Skalski JH, Limon JJ, Sharma P, Gargus MD, Nguyen C, Tang J, Coelho AL, Hogaboam CM, Crother TR, Underhill DM.

PLoS Pathog. 2018 Sep 20;14(9):e1007260. doi: 10.1371/journal.ppat.1007260. eCollection 2018 Sep.

4.

Commensal Fungi in Health and Disease.

Limon JJ, Skalski JH, Underhill DM.

Cell Host Microbe. 2017 Aug 9;22(2):156-165. doi: 10.1016/j.chom.2017.07.002. Review.

5.

Direct Antimicrobial Activity of IFN-β.

Kaplan A, Lee MW, Wolf AJ, Limon JJ, Becker CA, Ding M, Murali R, Lee EY, Liu GY, Wong GCL, Underhill DM.

J Immunol. 2017 May 15;198(10):4036-4045. doi: 10.4049/jimmunol.1601226. Epub 2017 Apr 14.

6.

Immunity to Commensal Fungi: Detente and Disease.

Wheeler ML, Limon JJ, Underhill DM.

Annu Rev Pathol. 2017 Jan 24;12:359-385. doi: 10.1146/annurev-pathol-052016-100342. Epub 2016 Dec 21. Review.

7.

Immunological Consequences of Intestinal Fungal Dysbiosis.

Wheeler ML, Limon JJ, Bar AS, Leal CA, Gargus M, Tang J, Brown J, Funari VA, Wang HL, Crother TR, Arditi M, Underhill DM, Iliev ID.

Cell Host Microbe. 2016 Jun 8;19(6):865-73. doi: 10.1016/j.chom.2016.05.003. Epub 2016 May 26.

8.

mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition.

Limon JJ, So L, Jellbauer S, Chiu H, Corado J, Sykes SM, Raffatellu M, Fruman DA.

Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):E5076-85. doi: 10.1073/pnas.1407104111. Epub 2014 Nov 10.

9.

Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia.

Janes MR, Vu C, Mallya S, Shieh MP, Limon JJ, Li LS, Jessen KA, Martin MB, Ren P, Lilly MB, Sender LS, Liu Y, Rommel C, Fruman DA.

Leukemia. 2013 Mar;27(3):586-94. doi: 10.1038/leu.2012.276. Epub 2012 Oct 1.

10.

Akt and mTOR in B Cell Activation and Differentiation.

Limon JJ, Fruman DA.

Front Immunol. 2012 Aug 6;3:228. doi: 10.3389/fimmu.2012.00228. eCollection 2012.

11.

B cell receptor signaling: picky about PI3Ks.

Limon JJ, Fruman DA.

Sci Signal. 2010 Aug 10;3(134):pe25. doi: 10.1126/scisignal.3134pe25. Review.

PMID:
20699473
12.

Foxo1 regulates marginal zone B-cell development.

Chen J, Limon JJ, Blanc C, Peng SL, Fruman DA.

Eur J Immunol. 2010 Jul;40(7):1890-6. doi: 10.1002/eji.200939817.

13.

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor.

Janes MR, Limon JJ, So L, Chen J, Lim RJ, Chavez MA, Vu C, Lilly MB, Mallya S, Ong ST, Konopleva M, Martin MB, Ren P, Liu Y, Rommel C, Fruman DA.

Nat Med. 2010 Feb;16(2):205-13. doi: 10.1038/nm.2091. Epub 2010 Jan 13.

14.

Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle.

Yaspelkis BB 3rd, Lessard SJ, Reeder DW, Limon JJ, Saito M, Rivas DA, Kvasha I, Hawley JA.

Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E941-9. Epub 2007 Jul 10.

15.

Insulin-stimulated plasma membrane association and activation of Akt2, aPKC zeta and aPKC lambda in high fat fed rodent skeletal muscle.

Herr HJ, Bernard JR, Reeder DW, Rivas DA, Limon JJ, Yaspelkis BB 3rd.

J Physiol. 2005 Jun 1;565(Pt 2):627-36. Epub 2005 Mar 31.

Supplemental Content

Loading ...
Support Center